Clinical Trial Update: A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effectiveness of PEA versus placebo for reducing pain severity and duration in migraines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• PEA (palmitoylethanolamide)

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Migraine | Phase 3 | Status: COMPLETED